Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
2.550
-0.090 (-3.41%)
Nov 21, 2024, 11:52 AM EST - Market open
Erasca Employees
Erasca had 126 employees as of December 31, 2023. The number of employees decreased by 3 or -2.33% compared to the previous year.
Employees
126
Change (1Y)
-3
Growth (1Y)
-2.33%
Revenue / Employee
n/a
Profits / Employee
-$1,262,849
Market Cap
720.95M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 126 | -3 | -2.33% |
Dec 31, 2022 | 129 | 6 | 4.88% |
Dec 31, 2021 | 123 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Pacira BioSciences | 712 |
Cytek Biosciences | 676 |
Castle Biosciences | 610 |
AbCellera Biologics | 586 |
Autolus Therapeutics | 471 |
Relay Therapeutics | 323 |
Evolus | 273 |
Pliant Therapeutics | 158 |
ERAS News
- 8 days ago - Erasca Reports Third Quarter 2024 Business Updates and Financial Results - GlobeNewsWire
- 16 days ago - Erasca to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Erasca Reports Second Quarter 2024 Business Updates and Financial Results - GlobeNewsWire
- 6 months ago - Erasca to Present at Upcoming Investor Conferences in June - GlobeNewsWire
- 6 months ago - Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 6 months ago - Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise - GlobeNewsWire
- 6 months ago - Erasca Announces Pricing of Underwritten Offering of Common Stock - GlobeNewsWire
- 7 months ago - Erasca Reports First Quarter 2024 Business Updates and Financial Results - GlobeNewsWire